BSE filing, NSE: INTERCONTINENTAL. Summary written from the filing by ALFA Finder's alert engine.
Medico Intercontinental Ltd: key numbers
- Share price
- ₹25.00
- Market cap
- ₹25.00 Cr
- Revenue (annual)
- ₹84.08 Cr
- Net profit (annual)
- ₹-3.20 Cr
- P/E (TTM)
- -6.3×Sector 43.1×
- Promoter holding
- 58.51%+0.00% QoQ
- FII holding
- 0.00%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Medico Intercontinental Ltd
All →Medico Intercontinental Other Announcement
The company filed its quarterly shareholding pattern for the period ended September 30, 2026, as required by SEBI regulations.
Medico Intercontinental Annual General Meeting
Medico Intercontinental Limited conducted its 42nd Annual General Meeting on September 30, 2026. Shareholders considered the adoption of FY26 financial statements and approved several related party transactions.
Medico Intercontinental Annual General Meeting
Medico Intercontinental Ltd will convene its Annual General Meeting on September 30, 2026. The company announced book closure from September 24 to September 30, 2026.
Medico Intercontinental Q1 FY27 Results: Net Loss of ₹4 Cr, Loss Widens
Medico Intercontinental Ltd reported revenue from operations of ₹20.7 Cr (-3.3% YoY) and a net loss of ₹4 Cr for Q1 FY27.
- Key figure
- Net loss ₹4 Cr
Medico Intercontinental Promoter Buying
Promoter Samir Dilipkumar Shah acquired 1,36,886 shares (1.37%) of Medico Intercontinental via open market purchase. Total promoter group holding increased to 60.48%.
Medico Intercontinental Promoter Buying: ₹0.54 Cr
Promoter Samir Dilipkumar Shah acquired 1,36,886 shares of Medico Intercontinental via open market. The transaction, valued at Rs. 0.54 Crore, increased his stake to 47.77%.
- Value
- ₹0.54 Cr
Other board meeting date announcements
All →Jenburkt Pharmaceuticals Board Meeting Date
Jenburkt Pharmaceuticals has intimated that its Board will meet on 3 Nov 2026 to consider Q2/H1-26 financial results. No decision has been taken yet.
Kingfa Science & Technology (India) Board Meeting Date
Kingfa informed exchanges its Board meeting is scheduled for November 5, 2026, to consider Q1/H1 FY27 unaudited results. Trading window stays closed until 48 hours post-announcement.
Orient Press Board Meeting Date
Orient Press Ltd intimated its Board meeting is scheduled for 05/11/2026, inter alia to approve unaudited Q3 FY27 results. The trading window stays closed till 48 hours after the intimation on 07/11/2026.
Surya Roshni Board Meeting Date
Surya Roshni's board will meet on November 7, 2026, to approve Q2 FY27 unaudited results. Trading window stays closed until November 9.
Prerna Infrabuild Board Meeting Date
Prerna Infrabuild will convene its board on 04/11/2026 to consider quarter results. The meeting is proposed under Regulation 33 of the LODR.
JSL Industries Board Meeting Date
JSL Industries intimates that its Board will meet on 5 Nov 2026 to consider unaudited Q1/H1 results. The trading window closes from 1 Oct 2026 until results are public.